Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 7, 1997, Pages 1541-1546

  Didier, Elizabeth S ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; FUMAGILLIN; FUMAGILLOL CHLOROACETYLCARBAMATE;

ANGIOGENESIS; ANTIFUNGAL ACTIVITY; ARTICLE; BINDING SITE; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VITRO STUDY; MICROSPORIDIOSIS; MICROSPORUM; MICROTUBULE; OPPORTUNISTIC INFECTION; POLYMERIZATION; PRIORITY JOURNAL;

EID: 0030858478     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.7.1541     Document Type: Article

References (61)

1. Aarons, E., D. Woodrow, W. S. Hollister, E. U. Canning, N. Francis, and B. G. Gazzard. 1994. Reversible renal failure caused by a microsporidian infection. AIDS 8:1119-1121.
2. Antoine, N., V. Bours, E. Heinen, L. J. Simar, and V. Castronovo. 1995. Stimulation of human B-lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis. J. Natl. Cancer Inst. 87:136-139.
3. Antoine, N., M. Daukandt, E. Hainen, L. J. Simar, and V. Castronovo. 1996. In vitro and in vivo stimulation of the murine immune system by AGM-1470, a potent angiogenesis inhibitor. Am. J. Pathol. 148:393-398.
4. Armstrong, E. 1976. Fumidil B and benomyl: chemical control of Nosema kingi in Drosophila willistoni. J. Invertebr. Pathol. 27:363-366.
5. Beauvais, B., C. Sarfati, S. Challier, and F. Derouin. 1994. In vitro model to assess effect of antimicrobial agents on Encephalitozoon cuniculi. Antimicrob. Agents Chemother. 38:2440-2448.
6. Blanshard, C., D. S. Ellis, S. P. Dowell, G. Tovey, and B. G. Gazzard. 1993. Electron microscopic changes in Enterocytozoon bieneusi following treatment with albendazole. J. Clin. Pathol. 46:898-902.
7. Blanshard, C., D. S. Ellis, D. G. Tovey, S. Dowell, and B. G. Gazzard. 1992. Treatment of intestinal microsporidiosis with albendazole in patients with AIDS. AIDS 6:311-313.
8. Cali, A., D. P. Kotler, and J. M. Orenstein. 1993. Septata intestinalis, N.G., N. Sp., and intestinal microsporidian associated with chronic diarrhea and dissemination in AIDS patients. J. Eukaryot. Microbiol. 40:101-112.
9. Canning, E. U., and W. S. Hollister. 1992. Human infections with microsporidia. Rev. Med. Microbiol. 3:35-42.
10. Canning, E. U., and J. Lom. 1986. The microsporidia of vertebrates. Academic Press, Inc., New York, N.Y.
11. Colbourn, N. I., W. S. Hollister, A. Curry, and E. U. Canning. 1994. Activity of albendazole against Encephalitozoon cuniculi in vitro. Eur. J. Protistol. 30:211-220.
12. 11a. Coyle, C. M., and L. M. Weiss. Unpublished data.
13. Davis, R. M., R. L. Font, M. S. Keisler, and J. A. Shadduck. 1990. Corneal microsporidiosis. A case report including ultrastructural observations. Ophthalmology 97:953-957.
14. DeGroote, M. A., G. S. Visvesvara, M. L. Wilson, N. J. Pieniazek, S. B. Slemenda, A. J. daSilva, G. J. Leitch, R. T. Bryan, and R. Reves. 1995. Polymerase chain reaction and culture confirmation of disseminated Encephalilozoon cuniculi in a patient with AIDS. Successful treatment with albendazole. J. Infect. Dis. 171:1375-1378.
15. Didier, E. S., P. J. Didier, D. N. Friedberg, S. A. Stenson, J. M. Orenstein, R. W. Yee, F. O. Tio, R. M. Davis, C. Vossbrinck, N. Millichamp, and J. A. Shadduck. 1991. Isolation and characterization of a new microsporidian, Encephalitozoon hellem (n. sp.) from three AIDS patients with keratoconjunctivitis. J. Infect. Dis. 163:617-621.
16. Didier, E. S., L. B. Rogers, A. D. Brush, S. Wong, V. Traina-Dorge, and D. C. Bertucci. 1996. Diagnosis of disseminated microsporidian Encephalitozoon hellem infection by PCR-Southern analysis and successful treatment with albendazole and fumagillin. J. Clin. Microbiol. 34:947-952.
17. Didier, E. S., L. B. Rogers, J. M. Orenstein, M. D. Baker, C. R. Vossbrinck, T. van Gool, R. Hartskeerl, R. Soave, and L. M. Beaudet. 1996. Characterization at Encephalitozoon (Septata) intestinalis isolates cultured from nasal mucosa and bronchoalveolar lavage fluids of two AIDS patients. J. Eukaryot. Microbiol. 43:34-43.
18. Diesenhouse, M. C., L. A. Wilson, G. F. Corrent, G. S. Visvesvara, H. E. Grossniklaus, and R. T. Bryan. 1993. Treatment of microsporidial keratoconjunctivitis with topical fumagillin. Am. J. Ophthalmol. 115:293-298.
19. Dieterich, D. T., E. Lew, D. P. Kotler, M. Poles, and J. M. Orenstein. 1994. Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J. Infect. Dis. 169:178-183.
20. Dore, G. J., D. J. Marriott, M. C. Hing, J. L. Harkness, and A. S. Field. 1995. Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole. Clin. Infect. Dis. 21:70-76.
21. Edlind, T. D., M. S. Bartlett, and J. W. Smith. 1991. Characterization of the β-tubulin gene of Pneumocystis carinii. J. Protozool. 38:62S-63S.
22. Edlind, T. D., J. Li, G. S. Visvesvara, N. H. Vodkin, G. L. McLaughlin, and S. K. Katiyar. 1996. Phylogenetic analysis of β-tubulin sequences from amitochondrial protozoa. Mol. Phylogenet. Evol. 5:359-367.
23. Edlind, T. D., G. Visvesvara, J. Li, and S. Katiyar. 1994. Cryptosporidium and microsporidial β-tubulin sequences: prediction of benzimidazole sensitivity and phylogeny. J. Eukaryot. Microbiol. 43:109S.
24. Franssen, F. F. J., J. T. Lumeij, and F. van Knapen. 1995. Susceptibility of Encephalitozoon cuniculi to several drugs in vitro. Antimicrob. Agents Chemother. 39:1265-1268.
25. Franzen, C., G. Faetkenheuer, B. Salzberger, A. Mueller, G. Mahrle, V. Diehl, and M. Schrappe. 1994. Intestinal microsporidiosis in patients with acquired immunodeficiency syndrome - report of three more German cases. Infection 22:417-419.
26. Franzen, C., A. Mueller, B. Salzberger, G. Faetkenheuer, V. Diehl, and M. Schrappe. 1996. Chronic rhinosinusitis in patients with AIDS: potential role of microsporidia. AIDS 10:687-688.
27. Garvey, M. J., P. G. Ambrose, and J. L. Ulmer. 1995. Topical fumagillin in the treatment of microsporidial keratoconjunctivitis in AIDS. Ann. Pharmacother. 29:872-874.
28. Hartwig, A., and A. Przelecka. 1971. Nucleic acids in intestine of Apis mellifica infected with Nosema apis and treated with fumagillin DCH. Cytochemical and autoradiographic studies. J. Invertebr. Pathol. 18:331-336.
29. Hori, A., S. Ikeyama, and K. Sudo. 1994. Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells. Biochem. Biophys. Res. Commun. 204:1067-1073.
30. Ingber, D., T. Fujita, S. Kishimoto, K. Sudo, T. Kanamaru, H. Brem, and J. Folkman. 1990. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348:555-557.
31. Jaronski, S. T. 1972. Cytochemical evidence for RNA synthesis inhibition by fumagillin. J. Antibiot. 25:327-331.
32. Joste, N. E., J. D. Rich, K. J. Busam, and D. A. Schwartz. 1996. Autopsy verification of Encephalitozoon intestinalis (microsporidiosis) eradication following albendazole therapy. Arch. Pathol. Lab. Med. 120:199-203.
33. Katiyar, S. K., V. R. Gordon, G. L. McLaughlin, and T. D. Edlind. 1994. Antiprotozoal activities of benzimidazoles and correlations with β-tubulin sequences. Antimicrob. Agents Chemother. 38:2086-2090.
34. Ketznelson, H., and C. A. Jamieson. 1952. Control of nosema disease of honey bees with fumagillin. Science 115:70.
35. Killough, J. H., G. B. Magill, and R. C. Smith. 1952. The treatment of amebiasis with fumagillin. Science 115:71-72.
36. Kusaka, M., K. Sudo, T. Fujita, S. Marue, F. Itoh, D. Ingber, and J. Folkman. 1991. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem. Biophys. Res. Commun. 174:1070-1076.
37. Lacey, E. 1985. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drue resistance to benzimidazoles. Int. J. Parasitol. 18:885-936.
38. Lowder, C. Y., J. T. McMahon, D. M. Meisler, E. M. Dodds, L. H. Calabrese, E. S. Didier, and A. Cali. 1996. Microsporidial keratoconjunctivitis caused by Septata intestinalis in a patient with acquired immunodeficiency syndrome. Am. J. Ophthalmol. 121:715-717.
39. McCowen, M. C., M. E. Callender, and J. F. Lawles, Jr. 1951. Fumagillin (H-3), a new antibiotic with amebicidal properties. Science 113:202-203.
40. Mossman, T. R., and T. A. T. Fong. 1989. Specific assays for cytokine production by T cells. J. Immunol. Methods 116:151-158.
41. Orenstein, J. M. 1991. Microsporidiosis in the acquired immunodeficiency syndrome. J. Parasitol. 77:843-864.
42. Pluda, J. M., K. Wyvill, J. Lietzau, D. Figg, M. W. Saville, B. Y. Nguyen, A. Foli, J. Bailey, M. Cooper, S. Broder, and R. Yarchoan. 1993. A phase I trial of TNP-470 (AGM-1470) administered to patients with HIV-associated Kaposi's sarcoma (KS), p. 61. In Program and abstracts of the 1st National Conference on Human Retroviruses and Related Infections. Infectious Disease Society of America Foundation for Retrovirology and Human Health, Alexandria, Va.
43. Rosberger, D. F., O. N. Serarevic, R. A. Erlandson, R. T. Bryan, D. A. Schwartz, and G. S. Visvesvara. 1993. Successful treatment of microsporidial keratoconjunctivitis with topical fumagillin in a patient with AIDS. Cornea 12:261-265.
44. Schmidt, E. C., and J. A. Shadduck. 1984. Mechanisms of resistance to the intracellular protozoan parasite. Encephalitozoon cuniculi, in mice. J. Immunol. 133:2712-2719.
45. Shadduck, J. A. 1980. Effect of fumagillin on in vitro multiplication of Encephalitozoon cuniculi. J. Protozool. 27:202-208.
46. Shadduck, J. A., R. A. Meccoli, R. Davis, and R. L. Font. 1990. First isolation of a microsporidian from a human patient. J. Infect. Dis. 162:773-776.
47. Shah, G. K., D. Pfister, L. E. Probst, P. Ferrieri, and E. Holland. 1995. Diagnosis of microsporidial keratitis by confocal microscopy and the chromatrope stain. Am. J. Ophthalmol. 121:89-91.
48. Silveira, H., and E. U. Canning. 1995. Vittaforma corneae N. Comb. for the human microsporidium Nosema corneum Shadduck, Meccoli, Davis, & Font, 1990, based on its ultrastructure in the liver of experimentally infected athymic mice. J. Eukaryot. Microbiol. 42:158-165.
49. Sobottka, I., H. Albrecht, H. Schaefer, J. Schottelius, G. S. Visvesvara, R. Laufs, and D. A. Schwartz. 1995. Disseminated Encephalitozoon (Septata) iniestinalis infection in a patient with AIDS: novel diagnostic approaches and autopsy-confirmed parasitological cure following treatment with albendazole. J. Clin. Microbiol. 33:2948-2952.
50. Sun, T., M. H. Kaplan, S. Teichberg, G. Weissman, T. Smilari, and C. Urmacher. 1994. Intestinal microsporidiosis. Report of five cases. Ann. Clin. Lab. Sci. 24:521-532.
51. Teicher, B. A., S. A. Holden, G. Ara, N. P. Dupuis, F. Liu, J. Yuan, M. Ikebe, and Y. Kakeji. 1995. Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy. Int. J. Cancer 61: 732-737.
52. Tsujimoto, H., A. Hagiwara, K. Osaki, T. Ohyama, T. Sakakibara, A. Sakuyama, M. Ohgaki, T. Imanishi, N. Watanabe, J. Yamazaki, M. Shirasu, C. Sakakura, M. Shimotsuma, and T. Takahashi. 1995. Therapeutic effects of the angiogenesis inhibitor TNP-470 against carcinomatous peritonitis in mice. Anti-Cancer Drugs 6:438-442.
53. Van Gool, T., F. Snijders, P. Reiss, J. K. M. Eeftinck-Schattenkerk, M. A. van den Bergh Weerman, J. F. W. M. Bartelsman, J. J. M. Bruins, E. U. Canning, and J. Dankert. 1993. Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique. J. Clin. Pathol. 46:694-699.
54. Wanke, C. A., M. Bhalla, A. R. Mattia, and H. M. Heller. 1993. Case records of the Massachusetts General Hospital (case report 51-1993). N. Engl. J. Med. 329:1946-1954.
55. Weber, R., R. T. Bryan, D. A. Schwartz, and R. I. Owen. 1994. Human microsporidial infections. Clin. Microbiol. Rev. 7:426-461.
56. Weber, R., B. Sauer, M. A. Spycher, P. Deplazes, R. Keller, R. Ammann, J. Briner, and R. Luethy. 1994. Detection of Septata intestinalis in stool specimens and coprodiagnostic monitoring of successful treatment with albendazole. Clin. Infect. Dis. 19:342-345.
57. Wilkins, J. H., N. Joshi, T. P. Margolis, V. Cevallos, and C. R. Dawson. 1994. Microsporidial keratoconjunctivitis treated successfully with a short course of fumagillin. Eye 8:703-704.
58. Yamaoka, M., T. Yamamoto, T. Masaki, S. Ikeyama, K. Sudo, and T. Fujita. 1993. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)-fumagillol (TNP-470; AGM-1470). Cancer Res. 53:4262-4267.
59. Yamaoka, M., T. Yamamoto, S. Ikeyama, K. Sudo, and T. Fujita. 1993. Angiogenesis inhibitor TNP-47 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res. 53:5233-5236.
60. Yanai, S., H. Okada, K. Saito, Y. Kuge, M. Misaki, Y. Ogawa, and H. Toguchi. 1995. Antitumor effect of arterial administration of a medium-chain triglyceride solution of an angiogenesis inhibitor, TNP-470, in rabbits bearing VX-2 carcinoma. Pharm. Res. 12:653-657.
61. Yanase, T., M. Tamura, K. Fujita, S. Kodama, and K. Tanaka. 1993. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res. 53:2566-2570.